Launch of Hyde Park Discovery between UChicago, Deerfield Management to accelerate research into life-saving treatments ...

Scientists have discovered a potential new treatment for familial hypercholesterolemia, inspired by signs seen in the Mona ...

Manas AI secures funding led by General Catalyst to scale AI-driven drug discovery, tackling cancer and rare diseases.

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...

Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is ...

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI leverages proprietary AI, generative computational chemistry ...

AI's hallucinations can drive drug discovery breakthroughs by generating novel molecular structures. Artificial intelligence ...

A new study from Oregon Health & Science University has uncovered how small molecules within bacteria interact with proteins, ...

PathAI, a leading provider of AI-powered technology for pathology, today announced a strategic partnership with Discovery ...

"Real-time analytics is more than just a tool—it’s a paradigm shift," says Dr. Aditya Dodda, an expert in building real-time ...

Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company at the forefront of AI-driven drug discovery, yesterday commented on the announcement of a $500 billion private-sector investment ...